147 related articles for article (PubMed ID: 26795951)
21. Alternative splicing and expression of human and mouse NFAT genes.
Vihma H; Pruunsild P; Timmusk T
Genomics; 2008 Nov; 92(5):279-91. PubMed ID: 18675896
[TBL] [Abstract][Full Text] [Related]
22. NFATc3 mediates the sensitivity of gastric cancer cells to arsenic sulfide.
Zhang X; Kang T; Zhang L; Tong Y; Ding W; Chen S
Oncotarget; 2017 Aug; 8(32):52735-52745. PubMed ID: 28881766
[TBL] [Abstract][Full Text] [Related]
23. Selective activation of NFAT by promyelocytic leukemia protein.
Lo YH; Wu CC; Shih HM; Lai MZ
Oncogene; 2008 Jun; 27(27):3821-30. PubMed ID: 18246125
[TBL] [Abstract][Full Text] [Related]
24. Regulation of different human NFAT isoforms by neuronal activity.
Vihma H; Luhakooder M; Pruunsild P; Timmusk T
J Neurochem; 2016 May; 137(3):394-408. PubMed ID: 26851544
[TBL] [Abstract][Full Text] [Related]
25. Cyclosporine A inhibits colorectal cancer proliferation probably by regulating expression levels of c-Myc, p21(WAF1/CIP1) and proliferating cell nuclear antigen.
Masuo T; Okamura S; Zhang Y; Mori M
Cancer Lett; 2009 Nov; 285(1):66-72. PubMed ID: 19481339
[TBL] [Abstract][Full Text] [Related]
26. EVI1 targets ΔNp63 and upregulates the cyclin dependent kinase inhibitor p21 independent of p53 to delay cell cycle progression and cell proliferation in colon cancer cells.
Nayak KB; Kuila N; Das Mohapatra A; Panda AK; Chakraborty S
Int J Biochem Cell Biol; 2013 Aug; 45(8):1568-76. PubMed ID: 23665236
[TBL] [Abstract][Full Text] [Related]
27. Overexpression of c-myc in pancreatic cancer caused by ectopic activation of NFATc1 and the Ca2+/calcineurin signaling pathway.
Buchholz M; Schatz A; Wagner M; Michl P; Linhart T; Adler G; Gress TM; Ellenrieder V
EMBO J; 2006 Aug; 25(15):3714-24. PubMed ID: 16874304
[TBL] [Abstract][Full Text] [Related]
28. Distinct activation properties of the nuclear factor of activated T-cells (NFAT) isoforms NFATc3 and NFATc4 in neurons.
Ulrich JD; Kim MS; Houlihan PR; Shutov LP; Mohapatra DP; Strack S; Usachev YM
J Biol Chem; 2012 Nov; 287(45):37594-609. PubMed ID: 22977251
[TBL] [Abstract][Full Text] [Related]
29. Myc suppression of the p21(Cip1) Cdk inhibitor influences the outcome of the p53 response to DNA damage.
Seoane J; Le HV; Massagué J
Nature; 2002 Oct; 419(6908):729-34. PubMed ID: 12384701
[TBL] [Abstract][Full Text] [Related]
30. Realgar induces apoptosis in the chronic lymphocytic leukemia cell line MEC‑1.
Liu X; Li X; Wang L; Lv X; Chen N; Li P; Lu K; Wang X
Mol Med Rep; 2013 Dec; 8(6):1866-70. PubMed ID: 24141727
[TBL] [Abstract][Full Text] [Related]
31. NFATc1 regulation of TRAIL expression in human intestinal cells.
Wang Q; Zhou Y; Weiss HL; Chow CW; Evers BM
PLoS One; 2011; 6(5):e19882. PubMed ID: 21603612
[TBL] [Abstract][Full Text] [Related]
32. Distinct roles of NFATc1 and NFATc4 in human primary myoblast differentiation and in the maintenance of reserve cells.
Perroud J; Bernheim L; Frieden M; Koenig S
J Cell Sci; 2017 Sep; 130(18):3083-3093. PubMed ID: 28760926
[TBL] [Abstract][Full Text] [Related]
33. Genome-scale functional analysis of the human genes modulating p53 activity by regulating MDM2 expression in a p53-independent manner.
Kim DM; Choi SH; Yeom YI; Min SH; Kim IC
Biochem Biophys Res Commun; 2016 Sep; 478(2):976-81. PubMed ID: 27524244
[TBL] [Abstract][Full Text] [Related]
34. Prohibitin promotes apoptosis of promyelocytic leukemia induced by arsenic sulfide.
He P; Liu Y; Qi J; Zhu H; Wang Y; Zhao J; Cheng X; Wang C; Zhang M
Int J Oncol; 2015 Dec; 47(6):2286-95. PubMed ID: 26498315
[TBL] [Abstract][Full Text] [Related]
35. Cellular stress and DNA damage invoke temporally distinct Mdm2, p53 and PML complexes and damage-specific nuclear relocalization.
Kurki S; Latonen L; Laiho M
J Cell Sci; 2003 Oct; 116(Pt 19):3917-25. PubMed ID: 12915590
[TBL] [Abstract][Full Text] [Related]
36. Cyclosporine A and tacrolimus inhibit bladder cancer growth through down-regulation of NFATc1.
Kawahara T; Kashiwagi E; Ide H; Li Y; Zheng Y; Miyamoto Y; Netto GJ; Ishiguro H; Miyamoto H
Oncotarget; 2015 Jan; 6(3):1582-93. PubMed ID: 25638160
[TBL] [Abstract][Full Text] [Related]
37. Mutant p53 protein is targeted by arsenic for degradation and plays a role in arsenic-mediated growth suppression.
Yan W; Zhang Y; Zhang J; Liu S; Cho SJ; Chen X
J Biol Chem; 2011 May; 286(20):17478-86. PubMed ID: 21454520
[TBL] [Abstract][Full Text] [Related]
38. Coordinated regulation of the immunoproteasome subunits by PML/RARα and PU.1 in acute promyelocytic leukemia.
Yang XW; Wang P; Liu JQ; Zhang H; Xi WD; Jia XH; Wang KK
Oncogene; 2014 May; 33(21):2700-8. PubMed ID: 23770850
[TBL] [Abstract][Full Text] [Related]
39. Activation of p53-dependent apoptosis by acute ablation of glycogen synthase kinase-3beta in colorectal cancer cells.
Ghosh JC; Altieri DC
Clin Cancer Res; 2005 Jun; 11(12):4580-8. PubMed ID: 15958644
[TBL] [Abstract][Full Text] [Related]
40. Differential contribution of NFATc2 and NFATc1 to TNF-alpha gene expression in T cells.
Kaminuma O; Kitamura F; Kitamura N; Hiroi T; Miyoshi H; Miyawaki A; Miyatake S
J Immunol; 2008 Jan; 180(1):319-26. PubMed ID: 18097033
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
